Left Atrial Size--another Differentiator for Cardiac Amyloidosis
Overview
Pulmonary Medicine
Affiliations
Background: The "sparkled" echocardiographic appearance of amyloid has become less visually obvious in the era of harmonic imaging. Significantly dilated atria in the setting of a normal sized ventricle may be another easy visual marker for cardiac amyloidosis.
Methods: A retrospective analysis of echocardiograms of patients with biopsy-proven cardiac amyloid compared with patients with hypertension was conducted. There were 36 patients in each group, and they were matched for left ventricular wall thickness, as well as age and sex.
Results: Patients with cardiac amyloid had significantly larger atria than the group with hypertension (left atrial areas 29 cm(2) versus 19 cm(2), p<0.001, AUC 0.84, volumes 100 cm(3) versus 55 cm(3), p<0.001, AUC 0.915). A volume of 69 cm(3) produced a specificity and sensitivity of 85% for amyloidosis.
Conclusions: Atrial dilatation can be used as a visual marker for cardiac amyloidosis. This may be a simple visual method to differentiate this infiltrative cardiomyopathy from left ventricular hypertrophy.
Ferkh A, Tjahjadi C, Stefani L, Geenty P, Byth K, De Silva K Front Cardiovasc Med. 2023; 10:1183485.
PMID: 37465456 PMC: 10351962. DOI: 10.3389/fcvm.2023.1183485.
A novel echocardiographic risk score for light-chain amyloidosis.
Geenty P, Sivapathan S, Stefani L, Zada M, Boyd A, Richards D Eur Heart J Open. 2023; 3(3):oead040.
PMID: 37143609 PMC: 10152390. DOI: 10.1093/ehjopen/oead040.
Echocardiographic assessment of cardiac amyloidosis.
Agrawal T, Nagueh S Heart Fail Rev. 2021; 27(5):1505-1513.
PMID: 34462900 DOI: 10.1007/s10741-021-10165-y.
Melero Polo J, Roteta Unceta-Barrenechea A, Revilla Marti P, Perez-Palacios R, Gracia Gutierrez A, Bueno Juana E Cardiol J. 2021; 30(2):266-275.
PMID: 34355777 PMC: 10129250. DOI: 10.5603/CJ.a2021.0085.
Brownrigg J, Lorenzini M, Lumley M, Elliott P ESC Heart Fail. 2019; 6(5):1041-1051.
PMID: 31487121 PMC: 6816075. DOI: 10.1002/ehf2.12511.